Home > Drug Search >
  • Bio-Type: Fab fragment
  •   > 
Drug Filter
Status:
Approved (11) Withdrawn (1) Phase Ⅲ (3) Phase Ⅱ (5) Phase Ⅰ (1)
Clinical Stage:
Pending (1) Active (6) Discontinued (2)
Company:
Genentech (2) Genzyme (1) Immunomedics (2) Janssen (3) Lilly (1) Novartis (1) UCB (3) Intas Biopharmaceuticals (1) Reliance Life Sciences (1) Glenveigh Pharmaceuticals (1) Pfenex (1) Formycon (1) Santo Holding GmbH (1) Effimune (1) Biomedical Primate Research Center (1) OSE Immunotherapeutics (1) KaloBios (1) Immunotech (1) Huasun Biological (1) Biogen (1) Celltech (1) Boehringer Ingelheim (2) BTG plc (1)
Indication:
Acute rejection in renal transplantation (1) Poisoning (1) ischaemic heart disorder (1) Crohn's disease (1) Diabetic macular edema (1) Transplant rejection (1) Wet age-related macular degeneration (3) Hepatocellular carcinoma (HCC) (1) Macular degeneration (1) Non small cell lung cancer (NSCLC) (1) Pneumonia (1) Psoriatic arthritis (1) Rheumatoid arthritis (RA) (2) Small cell lung cancer (SCLC) (1) Systemic lupus erythematosus (1) Osteomyelitis (1) Cardiac ischemic complications (1) Colorectal cancer (2) Ankylosing Spondylitis (AS) (1) Nosocomial Pneumonia (NP) (1) Diabetic foot ulcers (1) Cardiac Imaging (1) Age-related macular degeneration (AMD) (1) Unstable angina (1) Macular edema (1) Diagnostic agents (4) Retinal vein occlusion (1) Graft versus host disease (1) Bleeding (1) Emergency surgery (1) Choroidal neovascularisation (1)
Country:
Aprv. Year:
1995 (1) 1996 (2) 2006 (1) 2008 (1) 2011 (1) 2015 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top